Evidence from the mouse model system indicates that both humoral and cell-mediated immune responses participate in protective immunity against the facultative intracellular bacterium Brucella abortus (1-3, 5-13, 15; L. N. Araya, P. H. Elzer, G. E. Rowe, F. M. Enright, and A. J. Winter, J. Immunol., in press). Virulent strains of B. abortus such as strain 2308 nevertheless possess the capacity to produce chronic infections in cattle (14) or BALB/c mice (8) in the face of the immune response of the host. The basis of this property remains unexplained and distinguishes virulent strains from attenuated strain 19, which has long been used as a living vaccine in cattle (14) and is eliminated much more rapidly from the tissues of BALB/c mice (8) . In the studies reported here, we wished to determine the relative susceptibilities of virulent and attenuated strains of B. abortus to the protective effects of antibodies and T effector lymphocytes generated in response to infection. For this purpose for 30 min. Sera were frozen at -20°C unless used on the same day.
Ten-week-old recipient mice were injected intravenously with 3 x 107 T-lymphocyte-enriched spleen cells in 400 ,u of medium or with 200 p1 of serum diluted 1:2 in phosphatebuffered saline. Injections were made 2 h before or 2 h after challenge infections. Control mice were injected with an equivalent quantity of medium or phosphate-buffered saline, since it had been established that transfer of normal serum exerted no effect on the growth of the challenge strain (8; J. A. Montaraz and A. J. Winter, unpublished data), whereas transfer of normal T-cell-enriched splenocytes generally enhanced bacterial growth (8; Araya et al., in press). The reason for this enhancement is not known; it has been observed also in rats infected with Listeria monocytogenes (D. D. McGregor, personal communication). Recipients were killed at 1 week p.i., and numbers of B. abortus were determined in the spleen and in some experiments in the liver (8) . At 1 week p.i., mean log numbers of brucellae of strain 19 or 2308 in the spleens of control groups ranged from 6.0 to 6.5, while numbers in the liver were more than 10-fold lower. Log transformations of the data and statistical analyses were performed by methods previously employed (8, 16) .
Immune cells or serum from strain 19-infected donors conferred significant protection upon recipients challenged with strain 19 or 2308 (P < 0.01 to P < 0.001) (Fig. 1) . However, levels of protection provided by cells (1.5 versus 1.0 logs; P = 0.06) or serum (2.1 versus 1.2 logs; P < 0.001) were greater in groups challenged with strain 19 (Fig. 1) . In a repetition of this experiment (data not shown), recipients challenged with strain 19 again demonstrated higher levels of protection than those challenged with strain 2308 after transfer of immune cells (P < 0.01) or serum (P = 0.06). Further experiments were performed with serum from strain 19 donors to determine whether these relationships were influenced by the time of passive transfer in relation to infection. Spleen counts in all groups given serum were significantly below those of corresponding control groups (P < 0.01 to P < 0.001) (Fig. 2) . However, the level of protection in spleens provided against strain 19 was again greater than that provided against 2308, whether serum was transferred before infection (P < 0.001) or after infection (P < 0.01) (Fig. 2) . In accord with prior observations (Araya et al., in press), protection afforded against challenge infection with each individual strain was significantly greater (P < 0.001) when serum was given before infection (Fig. 2) . These relationships were unaffected by the small differences in numbers of brucellae recovered from the liver (Fig. 2) , because liver counts represented 10% or less of those in the spleen. In reciprocal experiments, protection provided to recipients challenged with strain 19 was found to be significantly greater than that provided to recipients challenged with strain 2308, whether the recipients had received antiserum specific for strain 19 (P < 0.01) or for strain 2308 (P < 0.01) (Fig. 3) . These data therefore demonstrate a consistently decreased effectiveness of antibodies in protecting against virulent strain 2308. The basis for this effect, which cannot be ascribed to differences in the specificity of protective antibodies induced by the two strains (Fig. 3) , has yet to be established. It may be related to the possession by virulent strains, but not by strain 19, of properties which allow survival in macrophages (4) even after opsonization with antibody.
In both experiments performed with immune T cells from donors infected with strain 2308, significant protection (P < 0.01) approaching 1 log was provided to recipients challenged with strain 2308 (Fig. 4) . Mean levels of protection against strain 19 were in both instances lower (Fig. 4) and achieved statistical significance with 12-week (P < 0.05) but not with 8-week donor cells. Differences in protection between groups challenged with strains 19 and 2308 were not significant in either experiment owing to the unusually large within-group variations in mice challenged with strain 19 (Fig. 4) 
